THERAPEUTIC METHOD FOR PROSTATIC CANCER USING LHRH ANTAGONIST

摘要

PPROBLEM TO BE SOLVED: To provide a therapeutic method for prostatic cancer that is designed so that the steep increase of the testosterone may be weakened or eliminated, which is induced by an agonist generated accompanying the existing treatment of the prostatic cancer with the LHRH (luteinizing hormone-releasing hormone) super-agonist. PSOLUTION: This is a method for treating prostatic cancer in a test object needing treatment in which the LHRH antagonist is administered to the test object, then, the prostatic cancer tissue is removed from the test object or broken. At this time, the LHRH antagonist is given to the test object, before the prostatic cancer tissue is removed or broken. PCOPYRIGHT: (C)2006,JPO&NCIPI